CAPR Insider Trading Activity and SEC Form 4 Filings
CAPR insider trading summary
Over the past 12 months, insiders at Capricor Therapeutics, Inc. (CAPR) reported 11 sales worth $6.8M by 3 insiders and no open-market purchases on SEC Form 4. Net insider selling was $6.8M.
Latest CAPR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 25, 2026 | Anthony Bergmann | Chief Financial Officer | Sell | $732K (24,100 @ $30.38) |
| Jun 25, 2026 | Karen Krasney | EVP, General Counsel | Sell | $732K (24,100 @ $30.38) |
| Jun 24, 2026 | Anthony Bergmann | Chief Financial Officer | Sell | $12K (400 @ $30.00) |
| Jun 24, 2026 | Karen Krasney | EVP, General Counsel | Sell | $12K (400 @ $30.00) |
| Jun 22, 2026 | Anthony Bergmann | Chief Financial Officer | Sell | $15K (500 @ $30.00) |
| Jun 22, 2026 | Karen Krasney | EVP, General Counsel | Sell | $15K (500 @ $30.00) |
| Apr 2, 2026 | Karimah Es Sabar | Insider | Sell | $241K (7,529 @ $32.00) |
| Apr 1, 2026 | Karimah Es Sabar | Insider | Sell | $1.7M (53,735 @ $31.03) |
| Mar 31, 2026 | Karen Krasney | EVP, General Counsel | Sell | $753K (25,000 @ $30.12) |
| Mar 31, 2026 | Anthony Bergmann | Chief Financial Officer | Sell | $753K (25,000 @ $30.13) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.